FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

377202005: Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram and codeine phosphate 16 milligram/1 each conventional release oral tablet (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3501597013 Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3676787012 Product containing precisely aspirin 325 milligram and carisoprodol 200 milligram and codeine phosphate 16 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4722731000005119 acetylsalicylsyre 325 mg + carisoprodol 200 mg + codeinphosphat 16 mg tablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) dansk modul


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Is a kombinationspræparat med acetylsalicylsyre false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Is a codeinphosphatprodukt false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has active ingredient Codeine phosphate false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has active ingredient Morphinan opioid false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has active ingredient Aspirin (substance) false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has active ingredient Codeine (substance) false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Is a acetylsalicylsyre + carisoprodol + codeinphosphat false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has active ingredient Carisoprodol (substance) false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has manufactured dose form Tablet false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has manufactured dose form Oral tablet true Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Is a Product containing aspirin in oral dose form (medicinal product form) false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Is a Codeine-containing product in oral dose form false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has basis of strength substance (attribute) Carisoprodol (substance) false Inferred relationship Some 1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength numerator value 200 false Inferred relationship Some 1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength denominator value en false Inferred relationship Some 1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength denominator value en false Inferred relationship Some 2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength numerator unit mg true Inferred relationship Some 3
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength denominator value en false Inferred relationship Some 3
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Some 3
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has active ingredient Carisoprodol (substance) false Inferred relationship Some 3
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has basis of strength substance (attribute) Carisoprodol (substance) false Inferred relationship Some 3
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength numerator value 200 false Inferred relationship Some 3
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has active ingredient Codeine phosphate false Inferred relationship Some 2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has basis of strength substance (attribute) Codeine phosphate false Inferred relationship Some 2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength numerator value 16 false Inferred relationship Some 2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has basis of strength substance (attribute) Aspirin (substance) true Inferred relationship Some 3
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength numerator value 325 false Inferred relationship Some 3
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has active ingredient Aspirin (substance) false Inferred relationship Some 1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has basis of strength substance (attribute) Aspirin (substance) false Inferred relationship Some 1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has presentation strength numerator value 325 false Inferred relationship Some 1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has precise active ingredient Carisoprodol (substance) false Inferred relationship Some 1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has precise active ingredient Codeine phosphate false Inferred relationship Some 2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Is a Aspirin- and carisoprodol- and codeine-containing product in oral dose form false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has precise active ingredient Aspirin (substance) true Inferred relationship Some 3
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Count of base of active ingredient tre false Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Is a Aspirin and carisoprodol and codeine only product in oral dose form true Inferred relationship Some
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has precise active ingredient Codeine phosphate true Inferred relationship Some 1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has basis of strength substance (attribute) Codeine phosphate true Inferred relationship Some 1
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has basis of strength substance (attribute) Carisoprodol (substance) true Inferred relationship Some 2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Has precise active ingredient Carisoprodol (substance) true Inferred relationship Some 2
Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet Plays role Antitussive therapeutic role (role) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start